Amedisys (Amedisys) Operating Cash Flow per Share : $3.22 (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Amedisys Operating Cash Flow per Share?

Amedisys's operating cash flow per share for the three months ended in Mar. 2024 was $-0.20. Amedisys's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $3.22.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Amedisys was 3.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -21.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Amedisys's Operating Cash Flow per Share or its related term are showing as below:

AMED' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -101.5 Med: 12 Max: 124.7
Current: -21.5

During the past 13 years, Amedisys's highest 3-Year average Operating Cash Flow per Share Growth Rate was 124.70% per year. The lowest was -101.50% per year. And the median was 12.00% per year.

AMED's 3-Year OCF Growth Rate is ranked worse than
83.78% of 481 companies
in the Healthcare Providers & Services industry
Industry Median: 9.5 vs AMED: -21.50

Amedisys Operating Cash Flow per Share Historical Data

The historical data trend for Amedisys's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Operating Cash Flow per Share Chart

Amedisys Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

6.12

8.69

5.73

4.08

4.21

Amedisys Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.80	1.87	-0.30	1.85	-0.20

Competitive Comparison of Amedisys's Operating Cash Flow per Share

For the Medical Care Facilities subindustry, Amedisys's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amedisys's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Amedisys's Price-to-Operating-Cash-Flow falls into.

Amedisys Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Amedisys's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	137.188	/	32.599
	=	4.21

Amedisys's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-6.541	/	32.979
	=	-0.20

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.22

Amedisys Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Amedisys's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Amedisys (Amedisys) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (NAS:AMED) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ADY:Germany ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Executives

Allyson Guidroz	officer: Chief Accounting Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard M Ashworth	director, officer: President and CEO	200 WILMOT ROAD, DEERFIELD IL 60015
Michael Paul North	officer: Chief Information Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Adam Y Holton	officer: Chief People Officer	C/O CHS INC., 5500 CENEX DRIVE, INVER GROVE HEIGHTS MN 55077
Denise M. Bohnert	officer: Chief Compliance Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Nick Muscato	officer: Chief Strategy Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard A Lechleiter	director	PO BOX 32890, LOUISVILLE KY 40232-2890
Bruce D Perkins	director	500 WEST MAIN STREET, LOUISVILLE KY 40202
Christopher Gerard	officer: Chief Operating Officer	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Vickie L Capps	director	2985 SCOTT STREET, VISTA CA 92083
Teresa L. Kline	director	C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Jeffrey A Rideout	director	2142 DEER OAK WAY, DANVILLE CA 94506
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
Molly Joel Coye	director	AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
David L Kemmerly	officer: See Remarks	3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816